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ABSTRACT -  Verapamil and other calcium blocker drugs are used as antihypertensive and antiarrhythmic 
in long term treatments and appropriate to be prescribed for pregnant women. It was studied in rats the effects 
of verapamil on dental germ calcification, the time of dental eruption in offspring born from treated mothers 
and on mother’s bone mineralization. The rats were divided in two groups: one received verapamil in doses of 
2.4 mg/rat/day and the other, 24 mg/rat/day. The animals were divided in two subgroups: one was treated 
during 10 weeks: 7 before mating and 3 during pregnancy, cesarean surgery performed on the 21st day; the  
other was treated in the same way but the offspring were born by natural delivery and the mothers’ treatment 
continued for 15 days. Plasma  calcium and phosphate were assayed in mothers and offspring. The offspring’s 
heads were isolated to histology of dental germs and determined mothers’ femoral bone fresh and dry 
weights. Results show that the higher dose verapamil lowered mother’s plasmatic calcium and phosphate 
while a significant lower values were observed in offspring as compared to their mothers.  Verapamil 
increased mothers’ femoral bone mineralization during mineralization but not after delivery. An increased 
calcium deposition of dental germ could not be demonstrated but verapamil significantly delayed  newborn’s 
dental eruption.  
RESUMO - O verapamil e outros  bloqueadores dos canais de cálcio são usados como antihipertensivos e 
antiarrítmicos tratamentos prolongados ou por toda a vida, podendo ser indicados em gestantes. Foi estudado 
o efeito do bloqueador dos canais de cálcio sobre o germe dental, tempo de erupção dentária de filhotes 
nascidos de mães tratadas e mineralização óssea nas mães. As fêmeas tratadas foram divididas em dois 
grupos: o primeiro recebeu verapamil na dose de 2,4 mg/rato/dia e o segundo, 24 mg/rato/dia. Os animais 
foram divididas em dois subgrupos: o primeiro recebeu a droga durante 10 semanas: 7 semanas antes do 
acasalamento e 3 semanas durante a gestação realizando-se a operação cesariana ao 21o dia; o outro  foi 
tratado como o primeiro, porem  os filhotes nasceram de parto natural e o tratamento das mães foi continuado 
por 15 dias. Foram determinados os níveis plasmáticos de cálcio e fosfato de mães e filhotes. As cabeças dos 
filhotes foram seccionadas para histologia dos germes dentários e determinados os pesos úmido e seco do 
osso femoral das mães. Os resultados mostraram que a droga, na dose mais elevada,  diminuiu os níveis 
séricos de cálcio e fosfato nas mães, enquanto que nos filhotes, os valores foram significativamente mais 
baixos em comparação com as mães. O verapamil causou aumento da mineralização óssea nas mães durante a 
gestação, mas não após o parto. Um aumento da calcificação dos germes dentários dos filhotes não pôde ser 
demonstrada, porem na dose mais elevada, o verapamil causou retardo significativo na erupção dentária. 
Introduction 
Verapamil, a phenylalkylamine, was the first 
calcium blocking channel to be clinically useful 
as antiarrhymic and antihypertensive and in 
angina pectoris, being still widely used 
nowadays. The drug acts by preventing ionized 
calcium from entering the cell and thus 
influencing calcium dependent processes  
(FLECKENSTEIN et al., 1967, 1969). It is 
proposed to act on slow voltage dependent  
calcium channels of the L type (NOWICKY et 
                                                           
 Correspondence should be addressed  to: Wilma P. Bastos-
Ramos. Faculdade de Odontologia-UNESP. Rua Francisco José 
Longo, 777 – CEP 12.245-000 – S. José dos Campos, S. Paulo. 
Tel. (012) 321-81-66, R.1201. Fax (011) 3667-6892. E-mail: 
wilmabastos@uol.com.br. 
al., 1985) of excitable cells. An interest arises 
whether calcium channel blockers influence the 
calcium balance in  bone tissues or not. The 
occurrence of calcium receptors of the L type 
channels in the rat osteoblasts was proposed by 
GRYGORCZYK et al. (1989) and calcium 
receptors and/or calcium channels were 
suggested to occur in the osteoclasts (DATTA et 
al., 1990; ZAIDI et al., 1989, 1990; RITCHIE et 
al., 1994). In in vitro experiments, HERMANN-
ERLEE et al. (1977) demonstrated that verapamil 
inhibited parathormone-stimulated release of 
calcium from  bone and LERNER and 
GUSTAFSON (1982) described its inhibitory 
effect on 45Ca release from bone in tissue culture. 
SIMEKOVA et al.(1987) found that verapamil 
enhanced bone calcium and phosphate  
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concentration in rat, suggesting that such action 
could be due to the inhibition of parathormone 
followed by inhibition of the osteoclasts function 
and preponderance of anabolic processes in the 
bone. In accordance, CHAGNAC et al. (1989) 
showed that verapamil inhibited parathormone-
induced bone reabsorption  in uremic rats. 
SAMNEGARD and SJÖDÉN (1992), in long 
term treatments of male and female rats with 
verapamil, found that the drug increased bone 
volume and  osteopenia in female displaying 
however an opposite effect in male rats; they 
argue that  the drug could be act upon sexual 
hormones indirectly inducing osteoporosis in the 
female and  stimulating  androgen hormones in 
males. Calcium channels blocking 
dihidropyridines (RITCHIE et al., 1994) are 
supposed to bind osteoclasts in cell culture, 
increasing intracellular calcium. FOX and 
DELLA-SANTINA (1989) reported in rats an 
increase in bone mineralization by verapamil. 
However, DURRIEZ et al. (1990) reported that 
verapamil  appeared to reduce the amount of 
heterotropic  bone formation in response to 
tenotomy in rats. Moreover, AMORIM (1995) 
described that blocking calcium channels 
isradipine did not influence alveolar reparative 
process  in wound due to dental excision.  
 Considering that: a) according several authors 
verapamil exerts some influence on bone 
mineralization and development; b) the drug can 
be administered to pregnant women and c) no 
data is referred about  a possible  repercussion on 
children’s dental calcification or eruption, we 
decided to carry out a preliminary study in rats, 
about the effects of verapamil in long term 
treatments of pregnant mothers, on the newborn 
dental germ mineralization and germination and, 
as a side control, on mothers’ bone 
mineralization. 
Material and Methods 
For the experiments, 60 Wistar rats in controlled 
good health conditions were used. Forty-one were 
virgin females, aged 90-100 days at the onset of the 
experiments and 19 were reproductive male rats. 
The female were divided into two groups according 
the doses of verapamil administered: 2.4 mg/rat/day 
(“low dose”- D1) and 24 mg/rat/day (“high dose”-
D2). The rats were divided in two subgroups: to the 
first, verapamil was administered during 7 weeks 
before mating and 3 weeks during pregnancy; the 
second was treated the same way but the 
administration of the drug continued for 15 days 
after natural delivery. The  drug  was  mixed  to  the  
drinking water added with sucrose (0.5 g/rat/day). 
Control groups of no treated rats were run in 
parallel. All the animals were weekly weighed. 
After the initial seven weeks of treatment it was 
determined the estrous phase, when female and 
male were put together overnight for mating. 
Diagnosis of pregnancy was determined by the 
presence of spermatozoa in the vaginal secretion 
(see NICHOLAS, 1949). At cesarean surgery or 15 
days after natural delivery, heparinized blood 
samples were taken from mothers and young and 
the animals were sacrificed.  Mother’s femoral 
bone  was removed and freed of adherent soft 
tissues; length, fresh and dry weights (120qC/24 
they hours) were assayed. The dry weight was 
considered as mineralization index, as used by 
SAMNEGARD and SJÖDÉN (1992). For 
microscopic histochemical  studies, the heads were 
excised, fixed in 10% formaldehyde for 24 hours, 
cut at medial sagital plane, hydrated, dehydrated, 
diaphanized, prepared in paraffin and  dyed for 
microscopy according Von KOSSA histochemical 
method (PEARSE, 1972). The dental germ tissue 
was examined by optical microscopy with 100 and 
200x magnification. It was observed pulp cells, 
alveolar tissue and  dental germ.  Dental 
germination period was observed along 15 days in 
offspring born from natural delivery. Assays of 
calcium and inorganic phosphate were carried out 
in plasma obtained from mothers and newborn rats, 
using a Beckman-Du 600  Spectrophotometer. 
Plasma calcium was determined by compleximetric 
method of o-cresolphtalein-complexon  using 
Merck Reagents. For plasmatic inorganic phosphate  
assay FISKE and SUBAROW (1925) method was 
used.  
 Mathematical-statistical processing: significance 
of the difference between groups was assessed by 
non-parametric variance analysis of Kruskal Wallis. 
A multiple comparison among groups was carried 
out using  the GMC computer program version 7.0, 
according CONOVER (1980).  
   
Results 
Femoral bone fresh and dry weights. Fresh 
and dry weights of mothers’ femoral bone were 
significantly increased  in the groups treated 
with verapamil during 10 weeks, with the lower 
and higher doses, a result indicating an 
increased mineralization. In the 12 weeks 
group, such response was not demonstrated, 
since fresh and dry femoral bones weight were 
not increased as compared to control.  The bone 
length was not changed in both groups. The 
results are in Table 1. 
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Table 1.  Femur fresh and  dry weight (mg) of mothers from control and verapamil groups in doses of 2.4 mg/rat/day (D1) 
and 24.0 mg/rat/day (D2), administered during 10** and 12 weeks.*** 
               10 weeks          12 weeks 
 Control 
(n=24)
Ver. D1 
(n=18)
Ver. D2 
(n=10)
Ver. D1 
(n=9)
Ver. D2 
(n=10)
Fresh weight 
Dry weight 
675 (r164)
306 (r32) 
698 (r53.1)* 
345 (r6.6)* 
850 (r59.4)* 
353 (r21.2)* 
697 (r44.2) 
320 (r15.0) 
707 (r128)
322 (r43.0)
*significant (increased weight); **7 weeks before mating and 3 weeks during pregnancy; ***7 weeks before mating, 3 weeks 
during pregnancy and 2 weeks after delivery. 
Plasmatic calcium and phosphate. In organic 
plasmatic calcium and phosphate concentration were 
not changed in mothers treated with the lower dose of 
verapamil (D1) during 10 weeks. However, their 
plasmatic content were significantly decreased with 
higher dose (D2) in  rats treated during 10 weeks as 
well as with both doses, in those treated along 12 
weeks. Regarding to  offspring, plasmatic calcium and  
phosphate were not changed at birth (cesarean). In 
those born by natural delivery, values were 
significantly decreased on the 15th. day, as compared 
to control. In every offspring groups, values were 
significantly lower than the respective mothers.  
Results are in Table 2.  
Table 2. Rats plasmatic calcium (mg/100 ml) and phosphate (mg/100 ml)  from control and verapamil treated groups with 
doses of 2.4mg/rat/day (D1) and 24mg/rat/day (D2) during 10*** and 12**** weeks. A. – Mothers; B – Offspring. 
A- MOTHERS    10 weeks       12 weeks 
 Control Ver. D1 Ver. D2 Ver. D1 Ver. D2 
Calcium 
Phosphate 
6.18 (r0.27) 
3.93 (r0.57) 
5.99 (r0.26)
3.90 (r0.12)
5.47 (r0.67)* 
2.83 (r0.71)* 
5.27 (r0.45)* 
3.08 (r0.47)* 
4.77 (r0.44)* 
2.80(r0.27)* 
B- OFFSPRING**  10 weeks        12 weeks 
 Control Ver. D1 Ver. D2 Ver. D1 Ver. D2 
Calcium 
Phosphate 
5.04 (r1.08) 
2.48 (r0.38) 
5.21 (r0.19)
2.41 (r0.19)
5.04 (r0.15)
2.36 (r0.93)
4.85 (r0.22)* 
2.22 (r0.28)* 
2.39 (r1.56)* 
1.57 (r0.60)* 
* significantly lower as compared with respective control mothers or offspring. ** values of calcium and phosphate in 
offspring significantly lower as compared to their respective mothers. *** 7 weeks before mating and 3 weeks during 
pregnancy. ****7 weeks before mating, 3 weeks during pregnancy and 2 weeks after delivery. 
Offspring body weight.  As compared to control, 
a  body weight loss in verapamil group related to 
doses and time of mother’s treatment was observed: 
doses of 2.4mg/rat/day for 10 weeks-7%; for 12 
weeks-16%. Doses of 24/mg/rat/day for 10 weeks-
20%; for 12 weeks-44%. 
Histology of dental germs. Histological dental germ 
studies of offspring showed no significant differences 
between treated and control groups. It was observed 
morphological characteristics of the dental tissues 
surrounding bone, as well as calcium deposition in the 
dental mineralized matrix. In the dental germ, a pulp 
cellular rich loose tissue, limited by long odontoblasts 
was observed besides thin layers of pre-dentine 
matrix,  mineralized dentine, a discrete layer  of 
enamel,  mineralized tissue surface and long shaped 
ameloblasts lying on the matrix. The surrounding 
trabecular bone tissue showed a regular and 
anastomosed pattern of regular calcium deposition. 
Dental eruption in newborn rats. In the control 
group, teeth eruption of  rats occurred at the 8th day 
of birth. This time was significantly delayed in  
those born from mothers treated with the higher 
dose of verapamil (24/mg/rat/day), occurring from 
the 10th  to the 12th day. The number of individuals 
examined were: control, 82; verapamil D1, 83; 
verapamil D2, 82. Results are in Table 3. 
Discussion 
There is a great medical, scientific and social 
interest  in the teratogenic effect of drugs given to 
mothers during  pregnancy. Regarding to calcium 
channel blockers, usually given in  long term 
treatments,  an adding interest refers to the possibility 
of such drugs to be a risk factor for the development 
of  osteoporosis, a crippling bone disease that poses  
as a major public health problem. Although results are 
not always concordant, several authors have 
established a role of calcium blocking channels in 
bone cells and tissue (HERMANN-ERLEE et al.,
1977; LERNER and GUSTAFSON, 1982; 
SIMEKOVA et al.,1987; CHAGNAC et al., 1989; 
ZAIDI et al., 1989, 1990; DURRIEZ et al., 1990; 
DATTA et al., 1990; SAMNEGARD and SJÖDÉN et
al., 1992; RICHTIE et al., 1994). However, a possible 
influence of these agents on the teeth mineralization, 
either adult’s or offspring’s has not yet been 
described. This work should be considered a first 
approach to the subject.  
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Table 3. Dental eruption in young rats born from verapamil treated mothers and control. Verapamil administered during 12 
weeks** in doses of 2.4 mg/rat/day (D1) and 24.0 mg/rat/day (D2).  
Period of dental eruption (days) in offspring, from treated and not treated mothers 
              Control            Verapamil D1            Verapamil D2 
                8 (n=9) 
                8 (n=6) 
                8 (n=10) 
                8 (n=6) 
                8 (n=9) 
                8 (n=7) 
                8 (n=7) 
                8 (n=9) 
                8 (n=10) 
                8 (n=9) 
                 9 (n=10) 
                 8 (n=2) 
                 8 (n=11) 
                 8 (n=9) 
                 8 (n=7) 
                 8 (n=10) 
                 8 (n=11) 
                 8 (n=9) 
                 9 (n=8) 
                 8 (n=6) 
                10 (n=6) 
                10 (n=9) 
                12 (n=2) 
                11 (n=11) 
                11 (n=9) 
                11 (n=7) 
                11 (n=10) 
                12 (n=11) 
                10 (n=9) 
                10 (n=8)     
8.0 (r2.5)* 8.2 (r2.6)* 10.8 (r0.8)* 
* Mean rSD. In brackets the number of offspring examined.  ** Seven weeks before mating, 3 weeks during pregnancy, 2 
weeks after birth. 
 Doses of verapamil used in our experiments can be 
considered to be adequate,  because during the long 
term treatment the mother rats seemed to thrive and 
increase their body weight. No disturbed behavior was 
observed  and no death occurred. To assure an  
acceptance of the drinking water with verapamil, then 
allowing a controlled ingestion of the drug,  sucrose 
was added to the solution, both in the control and 
treated groups. The two doses of verapamil were 
chosen on basis of the approximate maximal doses 
indicated to human, that is about  7.0 mg/kg/day. To 
the rat it was chosen a “small” dose (D1) 
corresponding to 8.0mg/kg/day and a ten times higher 
dose of 80 mg/kg/day (D2). They are similar to those 
used by SAMNEGARD and SJÖDÉN (1992). To 
avoid the stress of a long term daily injection, oral 
route was used. Verapamil was administered for 7 
weeks before and 3 weeks during pregnancy to be 
considered a chronically administration and along 15 
days after birth, to have a condition in which a 
newborn is milk-fed by a treated mother. Calcium-
phosphate balance is essential to rat normal bone 
mineralization. The dietary calcium-phosphate was 
adequate as shown by normal growth of control and 
treated mother rats. They were within the range 
proposed by McCOY  (1949) to normal development 
of the rat. No sign of rickets were observed. 
In our experiments, the femur is indicated to be 
more densely mineralized  in rats treated during 10 
weeks but not in those treated for 12 weeks. FOX 
and DELLA-SANTINA (1989) and 
SAMNEGARD and SJÖDÉN (1992) reported in 
verapamil treated rats an increase in  tibial bone 
mineralization, based in ash weight, in male rats. 
They reported an influence of sex since an opposite 
results was obtained in female, that is, bone 
mineralization was significantly reduced by 
verapamil. They attributed such differences  to a 
possible action of verapamil in stimulating 
androgen secretion, absent in the female and to 
lower intestinal absorption of calcium in female as 
influenced by verapamil, a fact  previously 
described in rats by WROBEL and MICHALSKA 
(1977), PENTO and JOHNSON (1983), SJÖDÉN 
et al. (1983). On the other hand, BROMAGE et al.
(1990) described, during pregnancy, a physiological 
higher calcium absorption. Our results could be 
explained, tentatively, by the previously referred 
data of literature: during pregnancy, but not after 
delivery, a higher bone mineralization in verapamil 
treated mothers should corresponded to a higher 
calcium absorption. A decreased bone reabsorption 
caused by verapamil could play a role, according 
the suggestion of RITCHIE et al. (1994) that 
calcium channels antagonists may bind to the 
calcium channel of the osteoclasts  and lock it in an 
open state, leading to increase intracellular calcium 
concentration.  
Regarding to dental germ, our initial hypothesis 
was that  verapamil could retard  mineralization and 
tissue organization. However, they appeared not to 
be influenced by the drug, at least under an optical 
microscopy viewing. On the other hand, verapamil 
caused a significant delay in the eruption of the teeth, 
suggesting an influence on  the organ organization. 
Maybe the histological methods used, although 
specific to detect mineralization, lacked sensivity for 
an accurate response. Histology of newly erupted teeth 
are currently under processing. A lower calcium blood 
serum concentration was observed in mothers treated 
with the higher doses of verapamil, in parallel with a 
higher mineralization of the tibial bone.  However, the 
two processes cannot be compared, because they bear 
quite different physiological conditions. 
Verapamil significantly decreased offspring’s 
body weight, an effect dose related. No significant 
sign of toxicity and no external malformation were 
observed. Au interesting finding by VILELA-
GOULART et al. (1999), was that plasmatic 
calcium, phosphate and total protein were 
significantly lower in offspring of treated and 
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control groups, total protein depression being over 
50%. In offspring born from mothers treated during 
10 weeks, values were comparable between 
individuals from treated and control groups. However, 
on the 15th. day after birth, these values were 
significantly decreased. One can suppose a 
physiological balance between mother and fetus, 
ensuring them, during pregnancy, a normal plasmatic 
calcium and phosphate levels, despite of  lower values 
in mothers, observed with higher doses.  
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